These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11904762)

  • 1. Loss of heterozygosity on chromosome 22 in human ependymomas.
    Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
    Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
    von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
    Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human ependymomas reveal frequent deletions on chromosomes 6 and 9.
    Huang B; Starostik P; Schraut H; Krauss J; Sörensen N; Roggendorf W
    Acta Neuropathol; 2003 Oct; 106(4):357-62. PubMed ID: 12898154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis.
    Schneider D; Monoranu CM; Huang B; Rutkowski S; Gerber NU; Krauss J; Puppe B; Roggendorf W
    Cancer Genet Cytogenet; 2009 Jun; 191(2):90-6. PubMed ID: 19446744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.
    Monoranu CM; Huang B; Zangen IL; Rutkowski S; Vince GH; Gerber NU; Puppe B; Roggendorf W
    Cancer Genet Cytogenet; 2008 Apr; 182(1):18-26. PubMed ID: 18328946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
    Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
    Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2.
    Hulsebos TJ; Oskam NT; Bijleveld EH; Westerveld A; Hermsen MA; van den Ouweland AM; Hamel BC; Tijssen CC
    Br J Cancer; 1999 Dec; 81(7):1150-4. PubMed ID: 10584875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer.
    Iida A; Kurose K; Isobe R; Akiyama F; Sakamoto G; Yoshimoto M; Kasumi F; Nakamura Y; Emi M
    Genes Chromosomes Cancer; 1998 Feb; 21(2):108-12. PubMed ID: 9491321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
    Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
    Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
    Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ
    Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray.
    Ammerlaan AC; de Bustos C; Ararou A; Buckley PG; Mantripragada KK; Verstegen MJ; Hulsebos TJ; Dumanski JP
    Genes Chromosomes Cancer; 2005 Aug; 43(4):329-38. PubMed ID: 15880457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
    Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
    Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma.
    Ward S; Harding B; Wilkins P; Harkness W; Hayward R; Darling JL; Thomas DG; Warr T
    Genes Chromosomes Cancer; 2001 Sep; 32(1):59-66. PubMed ID: 11477662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers.
    Castells A; Gusella JF; Ramesh V; Rustgi AK
    Cancer Res; 2000 Jun; 60(11):2836-9. PubMed ID: 10850424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
    Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
    Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of chromosome 1 in myxopapillary ependymoma suggests a region out of chromosome 22 as critical for tumour biology: a FISH analysis of four cases on touch imprint smears.
    Tamiolakis D; Papadopoulos N; Venizelos I; Lambropoulou M; Nikolaidou S; Bolioti S; Kiziridou A; Manavis J; Alexiadis G; Simopoulos C
    Cytopathology; 2006 Aug; 17(4):199-204. PubMed ID: 16879268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel regions of allelic loss in ependymomas by high-resolution allelotyping with 384 microsatellite markers.
    Tong CY; Zheng PP; Pang JC; Poon WS; Chang AR; Ng HK
    J Neurosurg; 2001 Jul; 95(1):9-14. PubMed ID: 11453403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
    Rubio MP; Correa KM; Ramesh V; MacCollin MM; Jacoby LB; von Deimling A; Gusella JF; Louis DN
    Cancer Res; 1994 Jan; 54(1):45-7. PubMed ID: 8261460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas.
    dos Reis PP; Poli-Frederico RC; dos Santos RM; Nishimoto IN; Kowalski LP; Rogatto SR
    Med Sci Monit; 2002 Mar; 8(3):BR89-94. PubMed ID: 11889455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.